Suppr超能文献

白种人口腔和口咽癌的病例对照研究以及八种代谢酶的基因变异

Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes.

作者信息

Buch Shama C, Nazar-Stewart Valle, Weissfeld Joel L, Romkes Marjorie

机构信息

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

出版信息

Head Neck. 2008 Sep;30(9):1139-47. doi: 10.1002/hed.20867.

Abstract

BACKGROUND

Genetic variation in xenobiotic metabolizing enzymes may explain differing susceptibilities to the cancer causing effects of tobacco and alcohol.

METHODS

We compared 203 oral squamous cell carcinoma cases and 416 controls for single nucleotide polymorphisms (SNPs) in 8 genes (CYP1A1, CYP2E1, MPO, mEH, GSTM1, GSTT1, GSTP1, and NAT2). Except for NAT2, genotype frequencies were similar in the 2 groups. We classified subjects as fast or slow NAT2 acetylators genotyping 13 NAT2 SNPs.

RESULTS

Fast acetylators were overrepresented in cases (53.7%) compared with controls (43.9%; odds ratio (OR) 1.55, 95% confidence interval (CI) 1.08-2.20; p value = .03). Gene-gene interaction testing suggested several cancer-NAT2 associations, with association strongest among persons without a CYP1A1 variant (*2C or *4) allele (OR 1.77, 95% CI 1.20-2.60, p value = .03) or with a variant MPO (463A) allele (OR 2.38, 95% CI 1.34-4.21, p value = .05).

CONCLUSION

These results implicate fast NAT2 acetylation as a risk factor for oral cancer.

摘要

背景

异生物素代谢酶的基因变异可能解释对烟草和酒精致癌作用的易感性差异。

方法

我们比较了203例口腔鳞状细胞癌病例和416例对照在8个基因(CYP1A1、CYP2E1、MPO、mEH、GSTM1、GSTT1、GSTP1和NAT2)中的单核苷酸多态性(SNP)。除NAT2外,两组的基因型频率相似。我们通过对13个NAT2 SNP进行基因分型,将受试者分为快速或慢速NAT2乙酰化者。

结果

与对照组(43.9%)相比,病例组中快速乙酰化者的比例过高(53.7%);比值比(OR)为1.55,95%置信区间(CI)为1.08 - 2.20;p值 = 0.03)。基因-基因相互作用测试表明存在几种癌症与NAT2的关联,在没有CYP1A1变异(2C或4)等位基因的人群中关联最强(OR 1.77,95% CI 1.20 - 2.60,p值 = 0.03),或与变异的MPO(463A)等位基因相关(OR 2.38,95% CI 1.34 - 4.21,p值 = 0.05)。

结论

这些结果表明快速NAT2乙酰化是口腔癌的一个危险因素。

相似文献

2
Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
Int J Cancer. 1999 Mar 1;80(5):685-8. doi: 10.1002/(sici)1097-0215(19990301)80:5<685::aid-ijc9>3.0.co;2-w.
7
Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer.
Oral Oncol. 2002 Jul;38(5):486-90. doi: 10.1016/s1368-8375(01)00086-0.
10
Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.
Cancer Epidemiol. 2013 Aug;37(4):505-11. doi: 10.1016/j.canep.2013.02.009. Epub 2013 Mar 21.

引用本文的文献

4
Global Scenario of Research in Oral Cancer.
J Maxillofac Oral Surg. 2019 Sep;18(3):354-359. doi: 10.1007/s12663-018-1166-4. Epub 2018 Oct 16.
6
Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
World J Surg Oncol. 2017 Aug 2;15(1):144. doi: 10.1186/s12957-017-1183-7.
8
MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.
Mol Clin Oncol. 2016 Apr;4(4):660-666. doi: 10.3892/mco.2016.768. Epub 2016 Feb 5.
9
CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14685-92. eCollection 2015.
10
CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.
Fam Cancer. 2016 Apr;15(2):201-14. doi: 10.1007/s10689-015-9849-1.

本文引用的文献

2
NQO1, MPO, and the risk of lung cancer: a HuGE review.
Genet Med. 2005 Sep;7(7):463-78. doi: 10.1097/01.gim.0000177530.55043.c1.
3
Glutathione S-transferase genotypes and cancer risk.
Cancer Lett. 2005 Apr 28;221(2):123-9. doi: 10.1016/j.canlet.2004.06.016.
4
Global cancer statistics, 2002.
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
5
Polymorphisms of GSTT1 and related genes in head and neck cancer risk.
Head Neck. 2004 Jan;26(1):63-70. doi: 10.1002/hed.10342.
7
The pathology of oral cancer.
Pathology. 2003 Oct;35(5):376-83. doi: 10.1080/00310290310001602558.
8
Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?
Otolaryngol Head Neck Surg. 2003 May;128(5):674-80. doi: 10.1016/S0194-59980300176-1.
10
Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer.
Oral Oncol. 2002 Jul;38(5):486-90. doi: 10.1016/s1368-8375(01)00086-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验